DOCSLIB.ORG

Subject: Approval of a New Degree Program - Cip 26.0102

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subject: Approval of a New Degree Program - Cip 26.0102 Item: AS: A-2 Tuesday, June 2, 2020 SUBJECT: APPROVAL OF A NEW DEGREE PROGRAM - CIP 26.0102 PROPOSED BOARD ACTION Approval of the following New Degree Program – CIP 26.0102: Bachelor of Science in Medical Biology BACKGROUND INFORMATION The proposed program is a Bachelor of Science in Medical Biology. The program will offer students pursuing professional/graduate studies (including Medical, Veterinary, Dental, Pharmacy and Physician Assistant) the rigor expected for admittance and content which will support their successful completion of such programs. This market is currently not being well-served by FAU’s programs. Students may pursue pre-professional studies with the B.S. in Biology, but there is no clear 4-year track for students to be best prepared for entrance exams and the rigors of professional schools. There are over 2,800 declared biology majors at FAU. According to the College of Science advising office, over 500 incoming first-time-in-college freshmen identify as “pre-health” every fall and the proposed degree will capture and support these students. The need for skilled medical professionals and biomedical researchers remains high worldwide. The proposed program, by nature of its course content, will also prepare students to enter a number of other careers, for example: laboratory technicians, forensic technicians, forensic analysts, toxicologists, genetic technologists, clinical scientists, clinical trial managers, public health microbiologists, biomedical research advisors, technical writers, science journalists, science advisors in business, industry and government, educators, pharmaceutical salespersons, health product managers, transplant coordinators, patent agents, occupational health and safety specialists, etc. IMPLEMENTATION PLAN/DATE Effective Fall 2020, pending approval by the Florida Atlantic University Board of Trustees. FISCAL IMPLICATIONS The BS in Medical Biology degree program is a repackaging of existing course offerings at FAU. As such, we anticipate that minimal, if any, new resources will be required to implement this program. Supporting Documentation: New Degree Proposal Form Presented by: Dr. Bret Danilowicz, Vice President for Academic Affairs & Provost Phone: 561-297-6350 Revised December 8, 2016 Board of Governors, State University System of Florida Request to Offer a New Degree Program (Please do not revise this proposal format without prior approval from Board staff) Florida Atlantic University Fall 2020 University Submitting Proposal Proposed Implementation Term Department of Biological Sciences CES College of Science Name of College(s) or School(s) Name of Department(s)/ Division(s) BS in Medical Biology Biomedical Sciences Academic Specialty or Field Complete Name of Degree 26.0102 Biomedical Sciences, General Proposed CIP Code The submission of this proposal constitutes a commitment by the university that, if the proposal is approved, the necessary financial resources and the criteria for establishing new programs have been met prior to the initiation of the program. Date Approved by the University Board of President Date Trustees Signature of Chair, Board of Date Vice President for Academic Date Trustees Affairs Provide headcount (HC) and full-time equivalent (FTE) student estimates of majors for Years 1 through 5. HC and FTE estimates should be identical to those in Table 1 in Appendix A. Indicate the program costs for the first and the fifth years of implementation as shown in the appropriate columns in Table 2 in Appendix A. Calculate an Educational and General (E&G) cost per FTE for Years 1 and 5 (Total E&G divided by FTE). Projected Implementation Projected Program Costs Enrollment Timeframe (From Table 2) (From Table 1) E&G Contract E&G Auxiliary HC FTE Cost per & Grants Total Cost Funds Funds FTE Funds Year 1 570 456 555 253,088 0 0 253,088 Year 2 943 754.4 Year 3 1244 995.2 Year 4 1549 1239 Year 5 1780 1424 595 1,058,664 0 0 1,058,664 Note: This outline and the questions pertaining to each section must be reproduced within the body of the proposal to ensure that all sections have been satisfactorily addressed. Tables 1 through 4 are to be included as Appendix A and not reproduced within the body of the proposals because this often causes errors in the automatic calculations. 1 Revised December 8, 2016 INTRODUCTION I. Program Description and Relationship to System-Level Goals A. Briefly describe within a few paragraphs the degree program under consideration, including (a) level; (b) emphases, including majors, concentrations, tracks, or specializations; (c) total number of credit hours; and (d) overall purpose, including examples of employment or education opportunities that may be available to program graduates. The Bachelor of Science in Medical Biology (CIP 26.0102), will offer students pursuing professional/graduate studies (including Medical, Veterinary, Dental, Pharmacy and Physician Assistant) the rigor expected for admittance and content which will support their successful completion of such programs. The curriculum will fulfill prerequisites of medically-focused schools by guiding the selection of additional advanced relevant courses and considering Pre-Professional entrance exams. The curriculum was established by a departmental (Biology) subcommittee comprised of faculty members with appropriate background and expertise (e.g. Dr. H. Jay Lyons previously served as Associate Professor and Chairman of the Department of Physiology and Pharmacology at Southeastern College of Osteopathic Medicine, Dr. Kailiang Jia’s credentials include an MS in Medical Genetics, an MD in Clinical Medicine and a PhD in Genetics and Molecular Biology, etc.). The committee considered existing baccalaureate level programs under the proposed CIP, MCAT exam content, and didactic medical school curricula in assembling the proposed curriculum. Completion of this undergraduate degree program will require a minimum of 120 credits. FAU currently offers a B.S. in Biology (CIP 26.0101), a flexible and holistic degree designed to train biologists. In this degree, students select specializations, including for example, ecology, marine science, environmental science, animal behavior and microbiology. Students currently may pursue Pre- Professional studies with the B.S. in Biology, but there is no clear 4-year track for students to be best prepared for entrance exams and the rigors of professional schools. FAU also offers a B.A. in Health Science (CIP 51.000) which was designed for students wishing to pursue careers as dieticians/nutritionists, health educators, athletic trainers, exercise physiologists, recreational specialists, social and community service managers, music therapists, counselors, etc. The newly proposed program is a focused degree program meant to serve the interests of medical and professional school hopefuls and will allow students pursuing professional and graduate programs in biomedicine to differentiate themselves with a diploma that reads Medical Biology. The focused curriculum will also support students and advisors throughout the university to more effectively chart academic plans of study specific to students’ future goals upon student entry to the university, which will bolster timely degree completion. Currently, there is a market not being well-served by FAU’s programs. There are over 2,800 declared biology majors at FAU. According to the Associate Dean of Undergraduate Studies, over 500 incoming first-time-in-college freshmen identify as “pre-health” every fall. The proposed degree will capture and support these students. We anticipate that, at its peak, the program will house approximately half (1,400) of the current biology major population (2,800), leaving 1,400 or more majors in the existing Biology CIP. We do not expect that the exponentially growing Health Science B.A., which currently has a population of > 800 students, to be impacted by establishment of the proposed Medical Biology BS, as students in the Health Science program are not preparing for entrance into medical, veterinary, or other professional schools. Although students can complete the proposed Medical Biology curriculum by making appropriate course selections within the existing Biology degree program options, the B.S. in Medical Biology curriculum has been specifically designed to guide students into the advanced coursework that will support their goals. Currently FAU undergraduate students are not required to access academic advising services or self-identify as pre-health majors. Enrollment by otherwise unidentified pre-health students in a designated major specific to their educational objectives will facilitate us in identifying and disseminating to them information pertinent to the achievement of their goals early in their academic programs. The 2 Revised December 8, 2016 relatively restrictive nature of the curriculum will also support students in timely degree completion with minimal excess hours. Although the BS in Medical Biology major has been designed to include prerequisites for medical and many other health-related professional schools such as pharmacy, dental, optometry, physician assistant, podiatry, or audiology, the program, by nature of its course content, will also prepare participants to enter a number of other careers, for example: laboratory technicians, forensic technicians, forensic analysts, toxicologists, genetic technologists, clinical scientists, clinical trial managers, public health microbiologists, biomedical research advisors, technical writers, science journalists,
Load more

Recommended publications
  • Print Special Issue Flyer
    IMPACT FACTOR 5.118 an Open Access Journal by MDPI Marine Drugs Research in Spain Guest Editors: Message from the Guest Editors Prof. Dr. Jaime Rodríguez Spain is surrounded for near 8000 km of coastline, which Departamento de Química makes it one of the most important countries to study the Fundamental. Facultad de Ciencias, Universidad de A chemistry and the biology of marine life. Compounds from Coruña, Campus da Zapateira classic marine natural product studies are dated from the s/n, 15071 A Coruña, Spain beginning of the 1970s, with the first publications from [email protected] marine organisms of the Canary Atlantic. These papers were published from one of the pioneers of marine natural Dr. Fernando Reyes products in Spain, late Prof. Antonio Gonzalez at the Fundación MEDINA, Avda del Conocimiento 34, Parque University of La Laguna in the Canary Islands, who set the Tecnológico Ciencias Salud, E- precedent for some other research groups from the 18016 Granada, Spain University of Cadiz, University of Salamanca, University of fernando.reyes@ Santiago de Compostela, or CSIC. medinaandalucia.es In this Special Issue on “Marine Drugs Research in Spain”, Dr. Javier Fernández we will pay tribute to these research schools, providing Universidad de la Laguna (ULL), Spanish researchers and institutions with a platform for Instituto Universitario de Bio- Orgáncia Antonio González publishing biomedical and chemical studies of substances (IUBOAG), 38206 San Cristobal de of marine origin. We welcome papers focused on structure La Laguna, Spain elucidation and the synthesis of marine compounds, or any [email protected] biological aspects about marine macro or microorganisms.
    [Show full text]
  • Get App Journal Flyer
    IMPACT FACTOR 5.118 marine drugs an Open Access Journal by MDPI Australia New Zealand Marine Biotechnology Society (ANZMBS) is affiliated with Marine Drugs IMPACT FACTOR marine drugs 5.118 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Orazio Taglialatela-Scafati The marine environment has become a recognized source Associate Editors for the discovery of bioactive compounds, as testified by Prof. Dr. Anake Kijjoa Prof. Dr. Vassilios Roussis the solid preclinical/clinical pipeline that currently exists Prof. Dr. Claudiu T. Supuran for marine-derived products. Marine Drugs is inviting Dr. Hitoshi Sashiwa contributions on new advances in marine natural product Prof. Dr. Marialuisa Menna Dr. Ipek Kurtboke chemistry, marine biotechnology, marine pharmacology Prof. Dr. Bill J. Baker and genomics related to the discovery of biologically and Prof. Dr. Marc Diederich therapeutically relevant marine natural products. Our goal is to share sound contributions in a timely fashion and in a manner that will be valued by the scientific community. Author Benefits Impact Factor 5.118 Q1 in “Pharmacology, Pharmacy”, Q1 in “Chemistry, Medicinal” (JCR categories) CiteScore 6.4 Q1 in “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, Q1 in “Pharmaceutical Science”, and Q1 in “Drug Discovery” (Scopus categories) Coverage by Leading Indexing Services SCIE-Science Citation Index Expanded (Clarivate Analytics), PubMed (NLM), MEDLINE (NLM), Scopus (Elsevier), MarinLit (RSC) Thorough Peer-Review Open Access Unlimited
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 5.118 an Open Access Journal by MDPI Pharmacokinetic Research of Marine Drugs Guest Editor: Message from the Guest Editor Prof. Dr. Alexander N. Shikov Marine species have become increasingly popular sources Saint-Petersburg State Chemical of new high-activity molecules. Papers about the isolation Pharmaceutical University, Saint- and identification of such compounds have increased Petersburg, Russia gradually. However, just a few of compounds are used in [email protected] clinical practice. It is essential for the development process of drugs to analyze active molecules through pharmacokinetics (PK). The understanding of absorption, Deadline for manuscript distribution, metabolism, and excretion (ADME) is the basis submissions: for theoretical drug design. Reliable analytical methods are closed (30 September 2020) required for understanding pharmacokinetics and metabolism. All routine techniques, alternative analytical methods, such as ELISA, and other indirect assays are necessary for studies on PK and ADME. This Special Issue is focused on the situation and frontiers of studies on the pharmacokinetics and metabolism of marine molecular drugs. Original research papers and all aspects of pharmacokinetics and metabolism are welcomed to highlight the potential of compounds isolated from marine species for the further development of marine drugs. mdpi.com/si/16929 SpeciaIslsue IMPACT FACTOR 5.118 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Dr. Orazio Taglialatela- During the past few decades there has been an ever Scafati increasing number of novel compounds discovered in the Department of Pharmacy, marine environment. This is exemplified by the robust University of Naples Federico II, Italy preclinical and clinical pipeline that currently exists for marine natural products.
    [Show full text]
  • Editor-In-Chief's Letter to Readers and Authors of Marine Drugs
    marine drugs Editorial Editor-in-Chief’s Letter to Readers and Authors of Marine Drugs Orazio Taglialatela-Scafati Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via Montesano 49, 80131 Naples, Italy; [email protected] In recent weeks, Scopus and Journal Citation Reports (JCR)/Science Edition (Clar- ivate Analytics) have released the bibliometric parameters CiteScore and Impact Factor, respectively. In both cases, Marine Drugs [1] has experienced a remarkable score increase (CiteScore from 5.1 to 6.4; Impact Factor from 4.073 to 5.118). Marine Drugs is now Q1 in the three Scopus categories “Pharmacology, Toxicology and Pharmaceutics”, “Pharmaceu- tical Science”, and “Drug Discovery”. Marine Drugs is also Q1 in the WoS JCR category “Chemistry, Medicinal” and in the newly reached category “Pharmacology & Pharmacy”. These great outcomes are certainly due to the high quality of experimental manuscripts and reviews that our Authors submit to the journal and to the invaluable help and sup- port from the Editorial Board Members, coordinated through the careful scrutiny of the Associate Editors (Prof. Dr. Bill J. Baker, Prof. Dr. Marc Diederich, Prof. Dr. Anake Kijjoa, Dr. Ipek Kurtboke, Prof. Dr. Marialuisa Menna, Prof. Dr. Vassilios Roussis, Dr. Hitoshi Sashiwa, and Prof. Dr. Claudiu T. Supuran). However, the process and performance of the journal are dependent upon the activity of the Editorial Office, an efficient team working hard to maintain the relationships with Authors, Reviewers and Editors. These are crucial factors for obtaining results such as a median time from submission to first decision of 11.7 days (first half of 2021).
    [Show full text]
  • MDPI Annual Report 2015: Academic Open Access Publishing Since 1996 Multidisciplinary Digital Publishing Institute (MDPI)
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Copyright, Fair Use, Scholarly Communication, etc. Libraries at University of Nebraska-Lincoln 9-2016 MDPI Annual Report 2015: Academic Open Access Publishing Since 1996 Multidisciplinary Digital Publishing Institute (MDPI) Follow this and additional works at: http://digitalcommons.unl.edu/scholcom Part of the Intellectual Property Law Commons, Scholarly Communication Commons, and the Scholarly Publishing Commons Multidisciplinary Digital Publishing Institute (MDPI), "MDPI Annual Report 2015: Academic Open Access Publishing Since 1996" (2016). Copyright, Fair Use, Scholarly Communication, etc.. 31. http://digitalcommons.unl.edu/scholcom/31 This Article is brought to you for free and open access by the Libraries at University of Nebraska-Lincoln at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Copyright, Fair Use, Scholarly Communication, etc. by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. ANNUAL REPORT 2015 MDPI Academic Open Access Publishing Since 1996 MDPI ANNUAL REPORT 2015 2 CONTENTS 3 20 YEARS OF OPEN ACCESS PUBLISHING 12 BOOK PUBLISHING IN 2015 12 About 5 2015 KEY FIGURES 12 Benefits of Publishing Open Access Books 5 Papers Published in MDPI Journals by with MDPI Region 12 Top 5 Books 5 Geographical Distribution of Authors and Reviewers 13 INSTITUTIONAL MEMBERSHIPS 5 Publication by Subject Area AND PARTNERSHIPS 5 Growth Based on Published Articles 13 Institutional Members 6
    [Show full text]